Growing Irrelevancy of Pre- versus Post-Market Divide for EU Medical Devices

Nanotechnology, mobile medical apps, 3-D printing, and other innovations in medical devices, companion diagnostics, and combination products, plus new Medical Device and In Vitro Diagnostic Device Regulations, are all part of the changing scientific, legislative, and regulatory landscape for Medical Devices in the EU. John Wilkinson, Director of Devices for the Medicines and Healthcare Products Regulatory Agency (MHRA), UK, and co-lead for DIA’s 28th EuroMeeting Medical Devices Theme, discusses these and related topics with DIA Global Forum Deputy Editor Dr. Alberto Grignolo.